Division of CSL Ltd.
Latest From Seqirus
India's Glenmark gets US Complete Response Letter for Ryaltris but emphasizes the FDA hasn’t faulted the clinical data for the product, and that the action won’t impact recent alliances for the rhinitis asset.
Dengvaxia, the dengue vaccine from Sanofi that was suspended in the Philippines last year, is among six new products to get a recommendation for marketing authorization from the European Medicines Agency this week.
The key to pediatric approval for a flu vaccine: a manufacturing root cause investigation and subsequent process improvements.
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Gynecological, Urological
- Infectious & Viral Diseases
- Neurology, Nervous System
- CSL Biotherapies
- North America
- Parent & Subsidiaries
- CSL Ltd.
- Senior Management
- John Anderson, SVP & Gen. Mgr.
- Contact Info
Phone: (919) 577-5000
45 & 75 Sidney St.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.